Price movement over the last 24 hours
Align Technology, Inc. vs YieldMax Universe Fund of Option Income ETFs — how do they compare? Align Technology, Inc. trades at $179.45 (market cap $12.86B), while YieldMax Universe Fund of Option Income ETFs trades at $7.85. The key difference: Align Technology, Inc. is trading nearer its 52-week high, YieldMax Universe Fund of Option Income ETFs nearer its low. Which is the better fit depends on your goals.
| ALGN | YMAX | |
|---|---|---|
Market Cap | $12.86B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $207.19 | $14.00 |
52-Week Low | $124.88 | $7.51 |
Enterprise Value | $11.92B | — |
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
YMAX trades at $7.92, down 0.75% today, with technical indicators showing a neutral to bearish bias. The ETF maintains a consistent weekly dividend distribution strategy, though key valuation and profitability metrics remain unavailable. Recent news highlights the fund's focus on generating income through covered call strategies on a portfolio of YieldMax ETFs.
The outlook centers on YMAX's high distribution yield strategy, which faces headwinds from the bearish moving average signal and market volatility dependence. Investment appeal lies in income generation, but risks include the fund's complex options strategy and expense ratio of 1.33%, with most distributions representing return of capital rather than earnings.
Trailing returns across standard periods
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →YMAX is an actively managed 'fund of funds' that provides equal-weighted exposure to the full suite of YieldMax option income ETFs. It is designed to generate high current income by aggregating the premiums from various single-stock and thematic covered call strategies, offering a diversified approach to high-yield option investing.
Read more on YMAX →